Enfusion Inc
NYSE:ENFN

Watchlist Manager
Enfusion Inc Logo
Enfusion Inc
NYSE:ENFN
Watchlist
Price: 10.1 USD
Market Cap: 1.3B USD
Have any thoughts about
Enfusion Inc?
Write Note

Enfusion Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Enfusion Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Enfusion Inc
NYSE:ENFN
Accrued Liabilities
$18.1m
CAGR 3-Years
35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Salesforce Inc
NYSE:CRM
Accrued Liabilities
$559m
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Palantir Technologies Inc
NYSE:PLTR
Accrued Liabilities
$277.2m
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Applovin Corp
NASDAQ:APP
Accrued Liabilities
$246.1m
CAGR 3-Years
29%
CAGR 5-Years
93%
CAGR 10-Years
N/A
Intuit Inc
NASDAQ:INTU
Accrued Liabilities
$1.1B
CAGR 3-Years
23%
CAGR 5-Years
24%
CAGR 10-Years
15%
Adobe Inc
NASDAQ:ADBE
Accrued Liabilities
$1.9B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
12%
No Stocks Found

Enfusion Inc
Glance View

Market Cap
1.3B USD
Industry
Technology

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. The company is headquartered in Chicago, Illinois. The company went IPO on 2021-10-21. The products and services that comprise its solution are designed to enable investment managers to take investment decisions in real time. The Company’s solution, comprised of mission critical systems integrated with a suite of technology-powered, managed services, serves the full investment lifecycle, drives insights into and control over the business activities of the investment manager and investment operations. Its solution’s end-to-end functionality includes Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System and Enfusion Analytics System. PMS able to comprehensively construct and re-balance investment portfolios, this system generates a real-time investment book of record. PMS module offers portfolio managers, traders, compliance teams and analysts the ability to electronically communicate trade orders.

ENFN Intrinsic Value
9.38 USD
Overvaluation 7%
Intrinsic Value
Price

See Also

What is Enfusion Inc's Accrued Liabilities?
Accrued Liabilities
18.1m USD

Based on the financial report for Dec 31, 2023, Enfusion Inc's Accrued Liabilities amounts to 18.1m USD.

What is Enfusion Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
35%

Over the last year, the Accrued Liabilities growth was 15%. The average annual Accrued Liabilities growth rates for Enfusion Inc have been 35% over the past three years .

Back to Top